DiaMedica Therapeutics (DMAC) Amortizatization of Intangibles (2020 - 2026)
DiaMedica Therapeutics (DMAC) reported Amortizatization of Intangibles of $190000.0 for Q1 2026, down 27.2% on a YoY basis from $261000.0 in Q1 2025, and down 24.6% quarter-over-quarter from $252000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Amortizatization of Intangibles for 7 years, with the latest figure at $190000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 27.2% year-over-year to $190000.0; the trailing twelve-month figure through Mar 2026 stood at $871000.0 (down 31.69% YoY), and the FY2025 full-year result was $942000.0, down 29.86% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $190000.0, down from $252000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $424000.0 in Q3 2023, with the low at -$120000.0 in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $218176.5 across 5 years, with a median of $249000.0 in 2025.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles sank 361.54% — and 2023, when it soared 909.52%.
- DiaMedica Therapeutics' Amortizatization of Intangibles stood at $129000.0 in 2022, then soared by 184.5% to $367000.0 in 2023, then declined by 10.08% to $330000.0 in 2024, then decreased by 23.64% to $252000.0 in 2025, then slipped by 24.6% to $190000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $190000.0 (Q1 2026), $252000.0 (Q4 2025), and $249000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | 190,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190,000.00 |
| Mar 31, 2026 | 190,000.00 |
| Dec 31, 2025 | 252,000.00 |
| Dec 31, 2025 | 252,000.00 |
| Sep 30, 2025 | 249,000.00 |
| Sep 30, 2025 | 249,000.00 |
| Jun 30, 2025 | 180,000.00 |
| Jun 30, 2025 | 180,000.00 |
| Mar 31, 2025 | 261,000.00 |
| Mar 31, 2025 | 261,000.00 |
| Dec 31, 2024 | 330,000.00 |
| Dec 31, 2024 | 330,000.00 |
| Sep 30, 2024 | 365,000.00 |
| Sep 30, 2024 | 365,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Mar 31, 2024 | 329,000.00 |
| Mar 31, 2024 | 329,000.00 |
| Dec 31, 2023 | 367,000.00 |
| Dec 31, 2023 | 367,000.00 |